IRIS
SONVICO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.613
AS - Asia 9.354
EU - Europa 6.265
SA - Sud America 1.215
AF - Africa 413
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 13
Totale 26.907
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.346
SG - Singapore 3.326
CN - Cina 2.506
VN - Vietnam 1.373
IT - Italia 1.173
IE - Irlanda 1.097
BR - Brasile 939
SE - Svezia 836
FI - Finlandia 738
HK - Hong Kong 667
DE - Germania 562
FR - Francia 479
BD - Bangladesh 410
UA - Ucraina 383
NL - Olanda 294
ZA - Sudafrica 290
TR - Turchia 272
GB - Regno Unito 195
IN - India 173
CA - Canada 153
RU - Federazione Russa 132
AR - Argentina 112
KR - Corea 89
AT - Austria 79
IQ - Iraq 75
JP - Giappone 68
MX - Messico 68
ID - Indonesia 67
ES - Italia 55
PL - Polonia 46
PK - Pakistan 40
BE - Belgio 39
CZ - Repubblica Ceca 38
TH - Thailandia 37
EC - Ecuador 33
CO - Colombia 30
TW - Taiwan 30
UZ - Uzbekistan 30
VE - Venezuela 29
PH - Filippine 28
AU - Australia 26
MA - Marocco 24
PT - Portogallo 23
PY - Paraguay 21
CL - Cile 19
MY - Malesia 19
DZ - Algeria 17
SA - Arabia Saudita 17
TN - Tunisia 16
AE - Emirati Arabi Uniti 15
JO - Giordania 15
CI - Costa d'Avorio 13
CR - Costa Rica 13
EU - Europa 13
KE - Kenya 13
LT - Lituania 13
RS - Serbia 13
IL - Israele 11
NP - Nepal 11
PE - Perù 11
AZ - Azerbaigian 10
BO - Bolivia 10
EG - Egitto 10
IR - Iran 10
UY - Uruguay 10
AL - Albania 9
ET - Etiopia 9
KZ - Kazakistan 9
LB - Libano 9
HR - Croazia 8
NZ - Nuova Zelanda 8
RO - Romania 8
HU - Ungheria 7
SY - Repubblica araba siriana 7
CH - Svizzera 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
MD - Moldavia 6
SN - Senegal 6
BG - Bulgaria 5
OM - Oman 5
GA - Gabon 4
GT - Guatemala 4
PA - Panama 4
AM - Armenia 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
LV - Lettonia 3
NO - Norvegia 3
PS - Palestinian Territory 3
BS - Bahamas 2
EE - Estonia 2
GE - Georgia 2
HN - Honduras 2
KW - Kuwait 2
KY - Cayman, isole 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
QA - Qatar 2
Totale 26.875
Salva come PNG Salva come JPEG
Città #
Singapore 1.626
Ashburn 1.272
Dublin 1.081
Chandler 914
San Jose 908
Santa Clara 689
Hong Kong 621
Beijing 589
Jacksonville 434
Dallas 406
Ho Chi Minh City 402
Dearborn 326
Ann Arbor 324
Parma 323
Boardman 293
Hanoi 280
Johannesburg 262
Nanjing 224
New York 218
Los Angeles 217
Lauterbourg 186
Izmir 185
Princeton 179
Shanghai 174
Hefei 145
Wilmington 122
Council Bluffs 119
Munich 116
Helsinki 104
Columbus 97
San Mateo 94
Buffalo 85
Milan 83
Bremen 81
Moscow 81
Shenyang 79
São Paulo 73
Nanchang 72
Seattle 71
Toronto 71
Woodbridge 71
Guangzhou 68
Da Nang 65
Seoul 65
Turku 62
Des Moines 58
Hebei 58
Houston 57
The Dalles 57
Haiphong 56
Vienna 56
Kunming 55
Chicago 52
Rome 50
Frankfurt am Main 48
Jakarta 48
Jiaxing 48
Dong Ket 47
Tianjin 47
Bologna 46
Jinan 44
Orem 44
Tokyo 42
Changsha 41
London 40
Reggio Emilia 39
Brussels 35
Ferrara 33
Groningen 33
Warsaw 33
Brooklyn 32
Fremont 31
Marseille 31
Pune 30
Shenzhen 30
Belo Horizonte 29
Nuremberg 28
San Francisco 28
Brno 27
Montreal 27
Stockholm 27
Atlanta 26
Phoenix 25
Amsterdam 24
Baghdad 24
Falls Church 23
Grafing 23
Rio de Janeiro 23
Tashkent 23
Mexico City 22
Norwalk 22
Zhengzhou 22
Konyaalti 21
Naples 21
Manchester 20
Mumbai 20
Poplar 19
Brasília 18
Chennai 18
Erbil 18
Totale 15.856
Salva come PNG Salva come JPEG
Nome #
Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays 327
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 247
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 234
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 229
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 228
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 225
Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens 211
Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases 208
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 205
Agglomerates Containing Pantoprazole Microparticles: Modulating the Drug Release 203
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 203
Identifying contact-mediated, localized toxic effects of MWCNT aggregates on epithelial monolayers: A single-cell monitoring toxicity assay 202
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 202
Opportunity and challenges of nasal powders: Drug formulation and delivery 202
Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery 202
A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant 193
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler 191
Mechanisms of formation and disintegration of alginate beads obtained by prilling 188
Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products 186
CHIMERAL AGGLOMERATES OF MICRONIZED POWDER FOR NASAL ADMINISTRATION OF ANALGESIC DRUG 179
Dynamics of water and small molecules in bioadhesive polymer films 175
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 174
Fluorescent Multifunctional Organic Nanoparticles for Drug Delivery and Bioimaging: A Tutorial Review 173
Chimeral agglomerates of microparticles for the administration of caffeine nasal powders 173
MULTILAYERED PHARMACEUTICAL FORMULATION 172
Intrapleural polymeric devices containing Cisplatin for malignant pleural Mesothelioma in a rat tumor model: a preliminary study. 170
Development of a nasal spray based on cyclodextrin/hydrophobically-modified hydroxypropyl-methyl cellulose for the prevention of viral respiratory infections 169
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 169
Application of quasi-elastic neutron scattering to the investigation of the dynamics and release properties of single-layer transdermal films containing lidocaine 168
Therapeutic effect of cyclosporine A-loading TPGS micelles on a mouse model of LPS-induced neuroinflammation 167
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 167
A NEW GASTRORETENTIVE DOSAGE FORM: FLOATING DOME MATRIX®. FORMULATION AND IN VITRO RELEASE STUDIES OF RIBOFLAVIN. 166
Assemblage of novel release modules for the development of adaptable drug delivery systems 165
Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate 165
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 164
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 163
Clyndamicin-Artesunate Combined Multi-Kinetics Drug Delivery System for Malaria Theraphy 162
Intrapleural adjuvant treatment of mesothelioma : The combination of cisplatin-pemetrexed in rat tumor model 162
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 161
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 161
Progesterone loading in lecithin/chitosan nanoparticles for transmucosal delivery 160
The effect of residual water on antacid activity of sucralfate gel dried by microwaves 160
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 159
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 159
A Liposome-Micelle-Hybrid (LMH) Oral Delivery System for Poorly Water-Soluble Drugs: Enhancing Solubilisation and Intestinal Transport 158
Cell penetrating peptides in ocular drug delivery: State of the art 157
Formulation of siRNA nanoparticles, transfection and enhanced adhesion -penetration in nasal mucosal tissue 156
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 155
A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide 154
Mean square hydrogen fluctuations in chitosan/lecithin nanoparticles from elastic neutron scattering experiments 154
Preliminary Investigation on Simvastatin-Loaded Polymeric Micelles in View of the Treatment of the Back of the Eye 154
Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2 153
Dynamics of lipid–saccharide nanoparticles by quasielastic neutron scattering 152
Polysaccharides: New Frontiers for Nasal Administration of Medicines 151
Chlorhexidine Salt-Loaded Polyurethane Orthodontic Chains: In Vitro Release and Antibacterial Activity Studies 151
Brain distribution of ribavirin after intranasal administration 150
Gel-like TPGS-Based Microemulsions for Imiquimod Dermal Delivery: Role of Mesostructure on the Uptake and Distribution into the Skin 150
PROGESTERONE LOADED LECITHIN/CHITOSAN NANOPARTICLES FOR TRANSMUCOSAL DELIVERY 150
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 150
Respicell(TM): An innovative dissolution apparatus for inhaled products 150
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 149
Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy 148
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 148
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 147
Structure of Self-Organized Multilayer Nanoparticles for Drug Delivery 147
Flexibility and drug release features of lipid/saccharide nanoparticles 147
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 147
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 147
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 146
Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery 145
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting 143
Les formes pharmaceutiques du futur 142
Dome Matrix® technology : effect of drug solubility on release kinetics of swellable delivery modules 142
Ucuùba Fat Characterization and Use to Obtain Lipid Nanoparticles by High-Pressure Homogenization with Full Factorial Design 142
Chimeral agglomerates of microparticles for nasal administration of analgesic drug powders 140
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate 140
Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for treatment of Orf Virus Infections 140
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 140
Crystallization of stable doped mannitol polymorphs and in vitro assessment of their safety as carriers for lung delivery 140
Assembled modules technology for site-specific prolonged delivery of norfloxacin 139
Module assemblage technology for floating systems: in vitro flotation and in vivo gastro-retention 137
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays 137
A consensus research agenda for optimising nasal drug delivery 136
Lecithin-chitosan nanoparticles for transmucosal delivery of progesterone via chimerical agglomerates 135
The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract 134
Nasal delivery as a strategy for the prevention and treatment of COVID-19 134
Novel O/W nanoemulsions for nasal administration: Structural hints in the selection of performing vehicles with enhanced mucopenetration 134
Modular systems fitted together for the controlled release of substances 133
Single layer transdermal film containing lidocaine: water and lidocaine mobility determined using neutron scattering 133
New modules, new assembly kits and new assembles for controlled release of substances 132
IN13 Backscattering Spectrometer at ILL: Looking for Motions in Macromolecules and Organisms 132
Hyaluronate nanoparticles included in polymer films for the prolonged release of vitamin E for the management of skin wounds 131
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs 128
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 127
Development and validation of a RP-HPLC method for the simultaneous detection and quantification of simvastatin's isoforms and coenzyme Q10 in lecithin/chitosan nanoparticles 126
COMPOSITION IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND TWO-COMPONENTS EXCIPIENTS, AND PROCESS FOR THEIR PREPARATION 125
From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs 124
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023) 123
Intrapleural application of polymeric films containing cisplatin and pemetrexed in a rat tumour model of malignant pleural mesothelioma 122
Compositions in powder from made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 121
Totale 16.177
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.775
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 0 0 0 0 0 0 0 0 0 75
2021/2022979 24 36 19 66 45 61 98 103 50 71 55 351
2022/20233.549 367 386 220 258 287 361 37 259 1.192 31 107 44
2023/20241.636 86 129 40 62 115 359 222 126 47 100 138 212
2024/20255.143 124 256 330 395 505 635 288 207 601 475 438 889
2025/202611.132 959 877 1.326 945 1.512 555 1.189 352 1.436 932 648 401
Totale 27.325